Inventor · Indianapolis, IN, US

Robert Dally

15Patents

7h-index

93Co-inventors

69Inventor score

Filing activity: Sep 26, 1995 → Feb 22, 2019

Most-cited inventions

Patent	Title	Area	Cited by	Status
US6187799A	Inhibition of raf kinase activity using aryl ureas	Chemistry; Metallurgy	53	Expired
US9156824B2	CDC7 inhibitors	Human Necessities	22	Active
US6660752B2	2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists	Chemistry; Metallurgy	12	Expired
US6353006B1	Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents	Chemistry; Metallurgy	11	Expired
US7320995B2	Benzimidazoles and benzothiazoles as inhibitors of map kinase	Chemistry; Metallurgy	10	Expired
US8217032B2	Selective estrogen receptor modulators for the treatment of vasomotor symptoms	Chemistry; Metallurgy	8	Active
US7745438B2	3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors	Chemistry; Metallurgy	8	Active
US5633277A	Sulfonamide aminomethylene derivatives as immunosuppressants	Human Necessities	3	Expired
US5686469A	Aminomethylene derivaties as immunosuppressants	Human Necessities	2	Expired
US8148387B2	AKT and P70 S6 kinase inhibitors	Chemistry; Metallurgy	2	Active
US6919371B2	2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists	Chemistry; Metallurgy	1	Expired
US11028074B2	CD73 inhibitors	Human Necessities	0	Active
US7863310B2	Kinase inhibitors	Chemistry; Metallurgy	0	Active
US7585977B2	Selective estrogen receptor modulators containing a phenylsulfonyl group	Chemistry; Metallurgy	0	Active
US9776992B2	1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers	Chemistry; Metallurgy	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.